UNH
UnitedHealth Group Incorporated
Price Chart
Latest Quote
$400.69
| Previous Close | $396.47 |
| Open | $399.54 |
| Day High | $404.00 |
| Day Low | $397.20 |
| Volume | 7,833,630 |
Stock Information
| Quarterly Dividend / Yield | $9.28 / 2.34% |
| Shares Outstanding | 908.14M |
| Quarterly Dividend Yield | 2.34% |
| Quarterly Dividend | $9.28 |
| Total Debt | $77.92B |
| Cash Equivalents | $31.23B |
| Revenue | $449.71B |
| Net Income | $12.04B |
| Sector | Healthcare |
| Industry | Healthcare Plans |
| Market Cap | $362.78B |
| P/E Ratio | 30.08 |
| EPS (TTM) | $13.28 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $414.18B |
| Sales | $449.71B |
| Income | $12.04B |
| Book/sh | $107.80 |
| Cash/sh | $34.39 |
| Employees | 390K |
Financial Ratios
| Quick Ratio | 0.72 |
| Current Ratio | 0.80 |
| Debt/Eq | 73.98 |
| EPS Growth TTM | -0.20% |
Returns & Margins
| ROA | 3.78% |
| ROE | 12.18% |
| Gross Margin | 18.80% |
| Operating Margin | 8.05% |
| Profit Margin | 2.68% |
Ownership
| Insider Ownership | 0.24% |
| Institutional Ownership | 85.85% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 19.11 |
| PEG | 1.31 |
| P/S | 0.81 |
| P/B | 3.71 |
Analyst Data
| Recommendation | buy |
| Target Price | $401.46 |
Technical Indicators
| SMA20 | $387.20 |
| SMA50 | $349.58 |
| SMA200 | $326.22 |
| RSI | 54.28 |
| ATR | 9.9043 |
| Shares Float | 905.44M |
| Short Float | 2.14% |
| Short Ratio | 2.11 |
| Volatility | 0.65 |
| Rel Volume | 1.47 |
Performance History
| Week | +5.04% |
| Month | +8.76% |
| Quarter | +40.52% |
| 6 Months | +19.30% |
| YTD | +19.67% |
| Year | +36.74% |
| 3 Years | -13.03% |
| 5 Years | +5.65% |
| 10 Years | +240.64% |
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-05 | $399.47 | 10,606,248 |
| 2026-06-04 | $396.47 | 12,666,100 |
| 2026-06-03 | $377.00 | 6,808,400 |
| 2026-06-02 | $377.92 | 3,874,400 |
| 2026-06-01 | $379.86 | 6,623,700 |
| 2026-05-29 | $380.31 | 10,257,900 |
| 2026-05-28 | $382.53 | 4,330,800 |
| 2026-05-27 | $384.01 | 4,544,000 |
| 2026-05-26 | $376.86 | 6,498,100 |
| 2026-05-22 | $388.47 | 5,598,600 |
| 2026-05-21 | $382.48 | 4,732,500 |
| 2026-05-20 | $383.30 | 7,783,900 |
| 2026-05-19 | $389.24 | 5,016,800 |
| 2026-05-18 | $391.13 | 8,400,700 |
| 2026-05-15 | $393.85 | 9,811,200 |
| 2026-05-14 | $399.09 | 5,342,500 |
| 2026-05-13 | $401.16 | 8,454,100 |
| 2026-05-12 | $396.39 | 9,236,300 |
| 2026-05-11 | $384.44 | 6,949,600 |
| 2026-05-08 | $379.98 | 6,455,100 |
| 2026-05-07 | $369.74 | 5,235,400 |
| 2026-05-06 | $367.28 | 6,695,500 |
About UnitedHealth Group Incorporated
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services with patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, public entities, life sciences companies and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease and drug therapy management. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; Medicaid plans, including Temporary Assistance to Needy Families; Children's Health Insurance Programs; Dual SNPs; Long-Term Services and Supports; Aged, Blind and Disabled; and other federal, state, and community health care programs. and health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. UnitedHealth Group Incorporated was founded in 1974 and is based in Eden Prairie, Minnesota.
đ° Latest News
Dow Jones Futures Rise, Techs Fall As AI Trade Cools; Jobs Report Looms
Investor's Business Daily âĸ 2026-06-05T21:15:02ZCan UNH Stock Sustain Its Recent 40% Rally?
Trefis âĸ 2026-06-05T20:20:26ZUnitedHealth, Eli Lilly Lead Healthcare Rebound as Investors Seek Stability
GuruFocus.com âĸ 2026-06-05T18:32:18ZUnitedHealth Stock Jumps 20% YTD: Should Investors Jump in Too?
Zacks âĸ 2026-06-05T16:03:00ZStock Market News for Jun 5, 2026
Zacks âĸ 2026-06-05T13:58:00Z3 High-Yielding Dividend Stocks That Just Raised Their Payouts
Motley Fool âĸ 2026-06-05T12:20:00ZStock Index Futures Slip as Tech Slide Deepens, U.S. Jobs Report in Focus
Barchart âĸ 2026-06-05T10:37:30ZThe Zacks Analyst Blog Highlights UnitedHealth, Donaldson, Lowe's and ePlus
Zacks âĸ 2026-06-05T08:33:00ZWhy Is UnitedHealth (UNH) Stock Rocketing Higher Today
StockStory âĸ 2026-06-05T03:25:30ZUnitedHealth Just Raised Its Dividend 5%. Why You Should Buy UNH Stock Here.
Barchart âĸ 2026-06-04T23:30:02ZIncome Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $364,650,000,000 | $310,879,000,000 | $280,664,000,000 | $244,545,000,000 |
| Cost Of Revenue | $364,650,000,000 | $310,879,000,000 | $280,664,000,000 | $244,545,000,000 |
| Total Revenue | $447,567,000,000 | $400,278,000,000 | $371,622,000,000 | $324,162,000,000 |
| Operating Revenue | $447,567,000,000 | $400,278,000,000 | $371,622,000,000 | $324,162,000,000 |
| Expenses | ||||
| Interest Expense | $4,002,000,000 | $3,906,000,000 | $3,246,000,000 | $2,092,000,000 |
| Total Expenses | $428,603,000,000 | $367,991,000,000 | $339,264,000,000 | $295,727,000,000 |
| Other Income Expense | $-265,000,000 | $-8,310,000,000 | $4,089,000,000 | $2,030,000,000 |
| Net Non Operating Interest Income Expense | $-4,002,000,000 | $-3,906,000,000 | $-3,246,000,000 | $-2,092,000,000 |
| Interest Expense Non Operating | $4,002,000,000 | $3,906,000,000 | $3,246,000,000 | $2,092,000,000 |
| Operating Expense | $63,953,000,000 | $57,112,000,000 | $58,600,000,000 | $51,182,000,000 |
| Other Operating Expenses | $59,592,000,000 | $53,013,000,000 | $54,628,000,000 | $47,782,000,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $12,056,000,000 | $14,405,000,000 | $22,381,000,000 | $20,120,000,000 |
| Net Interest Income | $-4,002,000,000 | $-3,906,000,000 | $-3,246,000,000 | $-2,092,000,000 |
| Normalized Income | $12,286,815,000 | $20,712,290,000 | $22,381,000,000 | $20,120,000,000 |
| Net Income From Continuing And Discontinued Operation | $12,056,000,000 | $14,405,000,000 | $22,381,000,000 | $20,120,000,000 |
| Total Operating Income As Reported | $18,964,000,000 | $32,287,000,000 | $32,358,000,000 | $28,435,000,000 |
| Net Income Common Stockholders | $12,056,000,000 | $14,405,000,000 | $22,381,000,000 | $20,120,000,000 |
| Net Income | $12,056,000,000 | $14,405,000,000 | $22,381,000,000 | $20,120,000,000 |
| Net Income Including Noncontrolling Interests | $12,807,000,000 | $15,242,000,000 | $23,144,000,000 | $20,639,000,000 |
| Net Income Continuous Operations | $12,807,000,000 | $15,242,000,000 | $23,144,000,000 | $20,639,000,000 |
| Pretax Income | $14,697,000,000 | $20,071,000,000 | $29,112,000,000 | $26,343,000,000 |
| Special Income Charges | $-265,000,000 | $-8,310,000,000 | $0 | $0 |
| Operating Income | $18,964,000,000 | $32,287,000,000 | $32,358,000,000 | $28,435,000,000 |
| Depreciation Amortization Depletion Income Statement | $4,361,000,000 | $4,099,000,000 | $3,972,000,000 | $3,400,000,000 |
| Depreciation And Amortization In Income Statement | $4,361,000,000 | $4,099,000,000 | $3,972,000,000 | $3,400,000,000 |
| Gross Profit | $82,917,000,000 | $89,399,000,000 | $90,958,000,000 | $79,617,000,000 |
| Per Share | ||||
| Diluted EPS | $13.23 | $15.51 | $23.86 | $21.18 |
| Basic EPS | $13.31 | $15.74 | $24.22 | $21.54 |
| Other | ||||
| Tax Effect Of Unusual Items | $-34,185,000 | $-2,002,710,000 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $23,325,000,000 | $36,386,000,000 | $36,330,000,000 | $31,835,000,000 |
| Total Unusual Items | $-265,000,000 | $-8,310,000,000 | $0 | $0 |
| Total Unusual Items Excluding Goodwill | $-265,000,000 | $-8,310,000,000 | $0 | $0 |
| Reconciled Depreciation | $4,361,000,000 | $4,099,000,000 | $3,972,000,000 | $3,400,000,000 |
| EBITDA (Bullshit earnings) | $23,060,000,000 | $28,076,000,000 | $36,330,000,000 | $31,835,000,000 |
| EBIT | $18,699,000,000 | $23,977,000,000 | $32,358,000,000 | $28,435,000,000 |
| Diluted Average Shares | $911,000,000 | $929,000,000 | $938,000,000 | $950,000,000 |
| Basic Average Shares | $905,838,620 | $915,000,000 | $924,000,000 | $934,000,000 |
| Diluted NI Availto Com Stockholders | $12,056,000,000 | $14,405,000,000 | $22,381,000,000 | $20,120,000,000 |
| Minority Interests | $-751,000,000 | $-837,000,000 | $-763,000,000 | $-519,000,000 |
| Tax Provision | $1,890,000,000 | $4,829,000,000 | $5,968,000,000 | $5,704,000,000 |
| Gain On Sale Of Business | $-265,000,000 | $-8,310,000,000 | $0 | $0 |
| Gain On Sale Of Security | - | - | $4,089,000,000 | $2,030,000,000 |
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-36,863,000,000 | $-37,344,000,000 | $-30,170,000,000 | $-29,981,000,000 |
| Total Assets | $309,581,000,000 | $298,278,000,000 | $273,720,000,000 | $245,705,000,000 |
| Total Non Current Assets | $218,999,000,000 | $212,499,000,000 | $195,283,000,000 | $176,636,000,000 |
| Other Non Current Assets | $23,013,000,000 | $19,590,000,000 | $17,298,000,000 | $15,027,000,000 |
| Goodwill And Other Intangible Assets | $130,973,000,000 | $130,002,000,000 | $118,926,000,000 | $107,753,000,000 |
| Other Intangible Assets | $20,474,000,000 | $23,268,000,000 | $15,194,000,000 | $14,401,000,000 |
| Current Assets | $90,582,000,000 | $85,779,000,000 | $78,437,000,000 | $69,069,000,000 |
| Other Current Assets | $9,746,000,000 | $8,212,000,000 | $9,839,000,000 | $10,708,000,000 |
| Receivables | $52,715,000,000 | $48,454,000,000 | $38,970,000,000 | $30,450,000,000 |
| Other Receivables | $29,697,000,000 | $26,089,000,000 | $17,694,000,000 | $12,769,000,000 |
| Accounts Receivable | $23,018,000,000 | $22,365,000,000 | $21,276,000,000 | $17,681,000,000 |
| Allowance For Doubtful Accounts Receivable | $-1,208,000,000 | $-985,000,000 | $-1,000,000,000 | $-877,000,000 |
| Gross Accounts Receivable | $24,226,000,000 | $23,350,000,000 | $22,276,000,000 | $18,558,000,000 |
| Cash Cash Equivalents And Short Term Investments | $28,121,000,000 | $29,113,000,000 | $29,628,000,000 | $27,911,000,000 |
| Cash And Cash Equivalents | $24,365,000,000 | $25,312,000,000 | $25,427,000,000 | $23,365,000,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Net Debt | $54,024,000,000 | $51,592,000,000 | $37,110,000,000 | $34,258,000,000 |
| Total Debt | $78,389,000,000 | $76,904,000,000 | $62,537,000,000 | $57,623,000,000 |
| Long Term Debt And Capital Lease Obligation | $72,320,000,000 | $72,359,000,000 | $58,263,000,000 | $54,513,000,000 |
| Long Term Debt | $72,320,000,000 | $72,359,000,000 | $58,263,000,000 | $54,513,000,000 |
| Current Debt And Capital Lease Obligation | $6,069,000,000 | $4,545,000,000 | $4,274,000,000 | $3,110,000,000 |
| Current Debt | $6,069,000,000 | $4,545,000,000 | $4,274,000,000 | $3,110,000,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $207,883,000,000 | $195,687,000,000 | $174,801,000,000 | $159,358,000,000 |
| Total Non Current Liabilities Net Minority Interest | $92,986,000,000 | $91,918,000,000 | $75,747,000,000 | $70,121,000,000 |
| Other Non Current Liabilities | $18,245,000,000 | $15,939,000,000 | $14,463,000,000 | $12,839,000,000 |
| Non Current Deferred Liabilities | $2,421,000,000 | $3,620,000,000 | $3,021,000,000 | $2,769,000,000 |
| Non Current Deferred Taxes Liabilities | $2,421,000,000 | $3,620,000,000 | $3,021,000,000 | $2,769,000,000 |
| Current Liabilities | $114,897,000,000 | $103,769,000,000 | $99,054,000,000 | $89,237,000,000 |
| Other Current Liabilities | $28,046,000,000 | $27,346,000,000 | $27,072,000,000 | $26,281,000,000 |
| Current Deferred Liabilities | $3,413,000,000 | $3,317,000,000 | $3,355,000,000 | $3,075,000,000 |
| Payables And Accrued Expenses | $77,369,000,000 | $68,561,000,000 | $64,353,000,000 | $56,771,000,000 |
| Payables | $77,369,000,000 | $68,561,000,000 | $64,353,000,000 | $56,771,000,000 |
| Accounts Payable | $77,369,000,000 | $68,561,000,000 | $64,353,000,000 | $56,771,000,000 |
| Equity | ||||
| Common Stock Equity | $94,110,000,000 | $92,658,000,000 | $88,756,000,000 | $77,772,000,000 |
| Total Equity Gross Minority Interest | $101,698,000,000 | $102,591,000,000 | $98,919,000,000 | $86,347,000,000 |
| Stockholders Equity | $94,110,000,000 | $92,658,000,000 | $88,756,000,000 | $77,772,000,000 |
| Gains Losses Not Affecting Retained Earnings | $-2,061,000,000 | $-3,387,000,000 | $-7,027,000,000 | $-8,393,000,000 |
| Other Equity Adjustments | $-2,061,000,000 | $-3,387,000,000 | $-7,027,000,000 | $-8,393,000,000 |
| Retained Earnings | $95,603,000,000 | $96,036,000,000 | $95,774,000,000 | $86,156,000,000 |
| Other | ||||
| Ordinary Shares Number | $905,838,620 | $915,000,000 | $924,000,000 | $934,000,000 |
| Share Issued | $905,838,620 | $915,000,000 | $924,000,000 | $934,000,000 |
| Tangible Book Value | $-36,863,000,000 | $-37,344,000,000 | $-30,170,000,000 | $-29,981,000,000 |
| Invested Capital | $172,499,000,000 | $169,562,000,000 | $151,293,000,000 | $135,395,000,000 |
| Working Capital | $-24,315,000,000 | $-17,990,000,000 | $-20,617,000,000 | $-20,168,000,000 |
| Total Capitalization | $166,430,000,000 | $165,017,000,000 | $147,019,000,000 | $132,285,000,000 |
| Minority Interest | $7,588,000,000 | $9,933,000,000 | $10,163,000,000 | $8,575,000,000 |
| Additional Paid In Capital | $559,000,000 | $0 | - | - |
| Capital Stock | $9,000,000 | $9,000,000 | $9,000,000 | $9,000,000 |
| Common Stock | $9,000,000 | $9,000,000 | $9,000,000 | $9,000,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Current Deferred Revenue | $3,413,000,000 | $3,317,000,000 | $3,355,000,000 | $3,075,000,000 |
| Investments And Advances | $54,251,000,000 | $52,354,000,000 | $47,609,000,000 | $43,728,000,000 |
| Goodwill | $110,499,000,000 | $106,734,000,000 | $103,732,000,000 | $93,352,000,000 |
| Net PPE | $10,762,000,000 | $10,553,000,000 | $11,450,000,000 | $10,128,000,000 |
| Accumulated Depreciation | $-7,546,000,000 | $-6,971,000,000 | $-7,039,000,000 | $-6,930,000,000 |
| Gross PPE | $18,308,000,000 | $17,524,000,000 | $18,489,000,000 | $17,058,000,000 |
| Machinery Furniture Equipment | $13,834,000,000 | $12,945,000,000 | $12,204,000,000 | $10,842,000,000 |
| Buildings And Improvements | $4,087,000,000 | $4,215,000,000 | $5,573,000,000 | $5,519,000,000 |
| Land And Improvements | $387,000,000 | $364,000,000 | $712,000,000 | $697,000,000 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $3,756,000,000 | $3,801,000,000 | $4,201,000,000 | $4,546,000,000 |
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $16,075,000,000 | $20,705,000,000 | $25,682,000,000 | $23,404,000,000 |
| Operating Activities | ||||
| Operating Cash Flow | $19,697,000,000 | $24,204,000,000 | $29,068,000,000 | $26,206,000,000 |
| Cash Flow From Continuing Operating Activities | $19,697,000,000 | $24,204,000,000 | $29,068,000,000 | $26,206,000,000 |
| Operating Gains Losses | $265,000,000 | $8,310,000,000 | - | - |
| Investing Activities | ||||
| Capital Expenditure | $-3,622,000,000 | $-3,499,000,000 | $-3,386,000,000 | $-2,802,000,000 |
| Investing Cash Flow | $-8,685,000,000 | $-20,527,000,000 | $-15,574,000,000 | $-28,476,000,000 |
| Cash Flow From Continuing Investing Activities | $-8,685,000,000 | $-20,527,000,000 | $-15,574,000,000 | $-28,476,000,000 |
| Net Other Investing Changes | $-915,000,000 | $-4,145,000,000 | $-275,000,000 | $2,621,000,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-5,545,000,000 | $-9,000,000,000 | $-8,000,000,000 | $-7,000,000,000 |
| Issuance Of Capital Stock | $827,000,000 | $1,846,000,000 | $1,353,000,000 | $1,253,000,000 |
| Financing Cash Flow | $-11,644,000,000 | $-3,512,000,000 | $-11,529,000,000 | $4,226,000,000 |
| Cash Flow From Continuing Financing Activities | $-11,644,000,000 | $-3,512,000,000 | $-11,529,000,000 | $4,226,000,000 |
| Net Other Financing Charges | $264,000,000 | $-3,485,000,000 | $-2,401,000,000 | $3,428,000,000 |
| Cash Dividends Paid | $-7,916,000,000 | $-7,533,000,000 | $-6,761,000,000 | $-5,991,000,000 |
| Common Stock Dividend Paid | $-7,916,000,000 | $-7,533,000,000 | $-6,761,000,000 | $-5,991,000,000 |
| Net Common Stock Issuance | $-4,718,000,000 | $-7,154,000,000 | $-6,647,000,000 | $-5,747,000,000 |
| Common Stock Issuance | $827,000,000 | $1,846,000,000 | $1,353,000,000 | $1,253,000,000 |
| Other | ||||
| Repayment Of Debt | $-3,050,000,000 | $-3,000,000,000 | $-2,125,000,000 | $-3,015,000,000 |
| Issuance Of Debt | $2,969,000,000 | $17,811,000,000 | $6,394,000,000 | $14,819,000,000 |
| Interest Paid Supplemental Data | $4,030,000,000 | $3,594,000,000 | $3,035,000,000 | $1,945,000,000 |
| Income Tax Paid Supplemental Data | $3,714,000,000 | $4,620,000,000 | $6,078,000,000 | $5,222,000,000 |
| End Cash Position | $24,365,000,000 | $25,312,000,000 | $25,427,000,000 | $23,365,000,000 |
| Other Cash Adjustment Outside Changein Cash | $-355,000,000 | $-219,000,000 | $0 | $0 |
| Beginning Cash Position | $25,312,000,000 | $25,427,000,000 | $23,365,000,000 | $21,375,000,000 |
| Effect Of Exchange Rate Changes | $40,000,000 | $-61,000,000 | $97,000,000 | $34,000,000 |
| Changes In Cash | $-632,000,000 | $165,000,000 | $1,965,000,000 | $1,956,000,000 |
| Common Stock Payments | $-5,545,000,000 | $-9,000,000,000 | $-8,000,000,000 | $-7,000,000,000 |
| Net Issuance Payments Of Debt | $726,000,000 | $14,660,000,000 | $4,280,000,000 | $12,536,000,000 |
| Net Short Term Debt Issuance | $807,000,000 | $-151,000,000 | $11,000,000 | $732,000,000 |
| Net Long Term Debt Issuance | $-81,000,000 | $14,811,000,000 | $4,269,000,000 | $11,804,000,000 |
| Long Term Debt Payments | $-3,050,000,000 | $-3,000,000,000 | $-2,125,000,000 | $-3,015,000,000 |
| Long Term Debt Issuance | $2,969,000,000 | $17,811,000,000 | $6,394,000,000 | $14,819,000,000 |
| Net Investment Purchase And Sale | $361,000,000 | $525,000,000 | $-1,777,000,000 | $-6,837,000,000 |
| Sale Of Investment | $17,734,000,000 | $27,833,000,000 | $16,537,000,000 | $11,988,000,000 |
| Purchase Of Investment | $-17,373,000,000 | $-27,308,000,000 | $-18,314,000,000 | $-18,825,000,000 |
| Net Business Purchase And Sale | $-4,509,000,000 | $-13,408,000,000 | $-10,136,000,000 | $-21,458,000,000 |
| Purchase Of Business | $-4,509,000,000 | $-13,408,000,000 | $-10,136,000,000 | $-21,458,000,000 |
| Net PPE Purchase And Sale | $-3,622,000,000 | $-3,499,000,000 | $-3,386,000,000 | $-2,802,000,000 |
| Purchase Of PPE | $-3,622,000,000 | $-3,499,000,000 | $-3,386,000,000 | $-2,802,000,000 |
| Change In Working Capital | $2,282,000,000 | $-808,000,000 | $1,643,000,000 | $2,246,000,000 |
| Change In Other Working Capital | $163,000,000 | $-197,000,000 | $203,000,000 | $126,000,000 |
| Change In Other Current Assets | $-4,606,000,000 | $-4,140,000,000 | $-2,444,000,000 | $-1,374,000,000 |
| Change In Payables And Accrued Expense | $7,489,000,000 | $4,966,000,000 | $6,998,000,000 | $6,017,000,000 |
| Change In Payable | $7,489,000,000 | $4,966,000,000 | $6,998,000,000 | $6,017,000,000 |
| Change In Account Payable | $1,665,000,000 | $2,463,000,000 | $3,516,000,000 | $1,964,000,000 |
| Change In Receivables | $-764,000,000 | $-1,437,000,000 | $-3,114,000,000 | $-2,523,000,000 |
| Changes In Account Receivables | $-764,000,000 | $-1,437,000,000 | $-3,114,000,000 | $-2,523,000,000 |
| Other Non Cash Items | $763,000,000 | $-3,361,000,000 | $-505,000,000 | $-331,000,000 |
| Stock Based Compensation | $971,000,000 | $1,018,000,000 | $1,059,000,000 | $925,000,000 |
| Deferred Tax | $-1,752,000,000 | $-296,000,000 | $-245,000,000 | $-673,000,000 |
| Deferred Income Tax | $-1,752,000,000 | $-296,000,000 | $-245,000,000 | $-673,000,000 |
| Depreciation Amortization Depletion | $4,361,000,000 | $4,099,000,000 | $3,972,000,000 | $3,400,000,000 |
| Depreciation And Amortization | $4,361,000,000 | $4,099,000,000 | $3,972,000,000 | $3,400,000,000 |
| Gain Loss On Sale Of Business | $265,000,000 | $8,310,000,000 | $0 | $0 |
| Net Income From Continuing Operations | $12,807,000,000 | $15,242,000,000 | $23,144,000,000 | $20,639,000,000 |
| Change In Other Current Liabilities | - | - | - | $-1,374,000,000 |